Boston Scientific Impairment of Intangible Assets decreased by 100.0% to $0.00 in Q3 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase signals potential issues with past acquisitions or declining market value of specific product lines.
Represents a non-cash charge taken when the carrying value of an intangible asset exceeds its fair value. This indicates...
Occurs across all industries; peers may report these periodically following large-scale acquisitions.
is_amgn_impairment_of_intangible_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q2 '23 | Q3 '23 | Q2 '24 | Q3 '24 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.00M | $128.00M | $197.00M | $7.00M | $125.00M | $57.00M | $1.00M | $276.00M | $0.00 | $46.00M | $0.00 |
| QoQ Change | — | +184.4% | +53.9% | -96.4% | >999% | -54.4% | -98.2% | >999% | -100.0% | — | -100.0% |
| YoY Change | — | — | — | -84.4% | -2.3% | +714.3% | -99.2% | +384.2% | -100.0% | -83.3% | — |